108 related articles for article (PubMed ID: 14960255)
1. Clinical effectiveness and costs of the Sugarbaker procedure for the treatment of pseudomyxoma peritonei.
Bryant J; Clegg AJ; Sidhu MK; Brodin H; Royle P; Davidson P
Health Technol Assess; 2004 Feb; 8(7):iii, 1-54. PubMed ID: 14960255
[TBL] [Abstract][Full Text] [Related]
2. Systematic review of the Sugarbaker procedure for pseudomyxoma peritonei.
Bryant J; Clegg AJ; Sidhu MK; Brodin H; Royle P; Davidson P
Br J Surg; 2005 Feb; 92(2):153-8. PubMed ID: 15685704
[TBL] [Abstract][Full Text] [Related]
3. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
[TBL] [Abstract][Full Text] [Related]
4. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
[TBL] [Abstract][Full Text] [Related]
5. Complete cytoreduction for pseudomyxoma peritonei is optimal but maximal tumor debulking may be beneficial in patients in whom complete tumor removal cannot be achieved.
Dayal S; Taflampas P; Riss S; Chandrakumaran K; Cecil TD; Mohamed F; Moran BJ
Dis Colon Rectum; 2013 Dec; 56(12):1366-72. PubMed ID: 24201390
[TBL] [Abstract][Full Text] [Related]
6. Survey on the incidence and management of pseudomyxoma peritonei in Japan.
Kitai T; Hirai T; Fujita T; Yonemura Y; Canbay E
Gan To Kagaku Ryoho; 2013 Aug; 40(8):1043-8. PubMed ID: 23986048
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of radical cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendiceal origin.
Järvinen P; Ristimäki A; Kantonen J; Lepistö A
Scand J Surg; 2013; 102(3):145-51. PubMed ID: 23963027
[TBL] [Abstract][Full Text] [Related]
8. Treating pseudomyxoma peritonei without heated intraperitoneal chemotherapy--a first look in New Zealand.
Wheeler BR; Reddy SK; Kenwright D; Keating JP
N Z Med J; 2014 Feb; 127(1389):31-9. PubMed ID: 24548955
[TBL] [Abstract][Full Text] [Related]
9. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
[TBL] [Abstract][Full Text] [Related]
10. Can a Benefit be Expected from Surgical Debulking of Unresectable Pseudomyxoma Peritonei?
Delhorme JB; Elias D; Varatharajah S; Benhaim L; Dumont F; Honoré C; Goéré D
Ann Surg Oncol; 2016 May; 23(5):1618-24. PubMed ID: 26678404
[TBL] [Abstract][Full Text] [Related]
11. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei in a liver-transplanted patient: a case report.
Thorgersen EB; Melum E; Folseraas T; Larsen SG; Line PD
World J Surg Oncol; 2018 Sep; 16(1):180. PubMed ID: 30185175
[TBL] [Abstract][Full Text] [Related]
12. Cytoreductive surgery plus perioperative intraperitoneal chemotherapy in pseudomyxoma peritonei: aspects of the learning curve.
Andréasson H; Lorant T; Påhlman L; Graf W; Mahteme H
Eur J Surg Oncol; 2014 Aug; 40(8):930-6. PubMed ID: 24656455
[TBL] [Abstract][Full Text] [Related]
13. Huge pseudomyxoma peritonei: Surgical strategies and procedures to employ to optimize the rate of complete cytoreductive surgery.
Benhaim L; Honoré C; Goéré D; Delhorme JB; Elias D
Eur J Surg Oncol; 2016 Apr; 42(4):552-7. PubMed ID: 26868165
[TBL] [Abstract][Full Text] [Related]
14. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in 1000 patients with perforated appendiceal epithelial tumours.
Ansari N; Chandrakumaran K; Dayal S; Mohamed F; Cecil TD; Moran BJ
Eur J Surg Oncol; 2016 Jul; 42(7):1035-41. PubMed ID: 27132072
[TBL] [Abstract][Full Text] [Related]
15. The INTRABEAM® Photon Radiotherapy System for the adjuvant treatment of early breast cancer: a systematic review and economic evaluation.
Picot J; Copley V; Colquitt JL; Kalita N; Hartwell D; Bryant J
Health Technol Assess; 2015 Aug; 19(69):1-190. PubMed ID: 26323045
[TBL] [Abstract][Full Text] [Related]
16. A systematic review on the efficacy of cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei.
Yan TD; Black D; Savady R; Sugarbaker PH
Ann Surg Oncol; 2007 Feb; 14(2):484-92. PubMed ID: 17054002
[TBL] [Abstract][Full Text] [Related]
17. Outcome differences between debulking surgery and cytoreductive surgery in patients with Pseudomyxoma peritonei.
Andréasson H; Graf W; Nygren P; Glimelius B; Mahteme H
Eur J Surg Oncol; 2012 Oct; 38(10):962-8. PubMed ID: 22809859
[TBL] [Abstract][Full Text] [Related]
18. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Chua TC; Moran BJ; Sugarbaker PH; Levine EA; Glehen O; Gilly FN; Baratti D; Deraco M; Elias D; Sardi A; Liauw W; Yan TD; Barrios P; Gómez Portilla A; de Hingh IH; Ceelen WP; Pelz JO; Piso P; González-Moreno S; Van Der Speeten K; Morris DL
J Clin Oncol; 2012 Jul; 30(20):2449-56. PubMed ID: 22614976
[TBL] [Abstract][Full Text] [Related]
19. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
